Outpatient antibiotic use in France between 2000 and 2010: After the nationwide campaign, it is time to focus on the elderly

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 1, 2014, Pages 71-77

  Bernier, Adeline ^a,b,c   Delarocque Astagneau, Elisabeth ^a,b,c   Ligier, Caroline ^a,b,c   Vibet, Marie Anne ^a,b,c   Guillemot, Didier ^a,b,c,d   Watier, Laurence ^a,b,c  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DRUG USE; EXOGENOUS VARIABLE; FOLLOW UP; FRANCE; GROUPS BY AGE; HUMAN; INFANT; MIDDLE AGED; NATIONAL HEALTH INSURANCE; NEWBORN; OUTPATIENT; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCHOOL CHILD; TIME SERIES ANALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OUTPATIENTS; PUBLIC HEALTH; YOUNG ADULT;

EID: 84891510982     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01813-13     Document Type: Article

References (20)

1. French GL. 2010. The continuing crisis in antibiotic resistance. Int. J. Antimicrob. Agents. 36(Suppl 3):S3-S7. http://dx.doi.org/10.1016/S0924-8579(10) 70003-0
2. European Centre for Disease Prevention and Control, European Medicines Agency. 2009. The bacterial challenge: time to react. European Centre for Disease Prevention and Control, Stockholm, Sweden. http://w ww.emea.europa.eu/ docs/en-GB/document-library/Report/2009/11/W C500008770.pdf.
3. Goossens H, Ferech M, Vander Stichele R, Elseviers M. 2005. Outpatient antibiotic use in Europe and association with resistance: a crossnational database study. Lancet 365:579-587. http://dx.doi.org/10.1016/S0140-6736(05) 17907-0.
4. Van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goosens H, Ferech M, European Antimicrobial Resistance Surveillance System Group, European Surveillance of Antimicrobial Consumption Project Group. 2008. Antimicrobial drug use and resistance in Europe. Emerging Infect. Dis. 14:1722-1730. http://dx.doi.org/10.3201/eid1411.070467.
5. Gonzales R, Steiner JF, Sande MA. 1997. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278:901-904. http://dx.doi.org/10.1001/jama.1997. 03550110039033.
6. Nyquist AC, Gonzales R, Steiner JF, Sande MA. 1998. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 279:875-877. http://dx.doi.org/10.1001/jama.279.11.875.
7. Gonzales R, Malone DC, Maselli JH, Sande MA. 2001. Excessive antibiotic use for acute respiratory infections in the United States. Clin. Infect. Dis. 33:757-762. http://dx.doi.org/10.1086/322627.
8. Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle PY, Watier L, Guillemot D. 2009. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 6:e1000084. http://dx.doi.org/10.1371/journal.pmed.1000084.
9. Valleron AJ, Bouvet E, Garnerin P, Ménarès J, Heard I, Letrait S, Lefaucheux J. 1986. A computer network for the surveillance of communicable diseases: the French experiment. Am. J. Public Health 76:1289-1292. http://dx.doi.org/10.2105/AJPH.76.11.1289.
10. Box GE, Jenkins GM. 1976. Time series analysis: forecasting and control, revised. Holden-Day, San Francisco, CA.
11. Shumway R, Stoffer D. 2000. Time series analysis and its applications. Springer, New York, NY.
12. Helfenstein U. 1996. Box-Jenkins modelling in medical research. Stat. Methods Med. Res. 5:3-22. http://dx.doi.org/10.1177/096228029600500102.
13. Box GE, Tiao GC. 1975. Intervention analysis with applications to economic and environmental problems. J. Am. Stat. Assoc. 70:70-79. http://dx.doi.org/10.1080/01621459.1975.10480264.
14. Bernier A, Ligier C, Guillemot D, Watier L. 2013. Did media attention of the 2009 A(H1N1) influenza epidemic increase outpatient antibiotic use in France? A time-series analysis. PLoS One 8:e69075. http://dx.doi.org/10.1371/ journal.pone.0069075.
15. Institut National de Veille Sanitaire. 2013. Couverture par le vaccine antipneumococcique conjugé. Institut National de Veille Sanitaire, Saint-Maurice, France. http://www.invs.sante.fr/Dossiers-thematiques/Maladie s-infectieuses/Maladies-a-prevention-vaccinale/Couverture-vaccinale/D onnees/Pneumocoque. Accessed 15 March 2013.
16. Dommergues MA, Hentgen V. 2012. Decreased paediatric antibiotic consumption in France between 2000 and 2010. Scand. J. Infect. Dis. 44: 495501. http://dx.doi.org/10.3109/00365548.2012.669840.
17. Dunais B, Van Dijken C, Bruno P, Touboul P, Carsenti-Dellamonica H, Pradier C. 2011. Antibiotic prescriptions in French day-care centres: 1999-2008. Arch. Dis. Child. 96:1033-1037. http://dx.doi.org/10.1136/adc.2010.207969.
18. Huttner B, Goossens H, Verheij T, Harbarth S. 2010. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect. Dis. 10:17-31. http://dx.doi.org/10.1016/S1473-3099(09)70305-6.
19. Goossens H, Coenen S, Costers M, De Corte S, De Sutter A, Gordts B, Laurier L, Struelens M. 2008. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill. 13(46): pii-19036. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId-19036.
20. Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O. 2008. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect. Dis. 8:125-132. http://dx.doi.org/10. 1016/S1473-3099(08)70017-3.